190 related articles for article (PubMed ID: 32130573)
1. The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis.
Akdeniz D; Klaver MM; Smith CZA; Koppert LB; Hooning MJ
Cancer Causes Control; 2020 May; 31(5):403-416. PubMed ID: 32130573
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for contralateral breast cancer in postmenopausal breast cancer survivors in the NIH-AARP Diet and Health Study.
Ramin C; Mullooly M; Schonfeld SJ; Advani PG; Bodelon C; Gierach GL; Berrington de González A
Cancer Causes Control; 2021 Aug; 32(8):803-813. PubMed ID: 33877513
[TBL] [Abstract][Full Text] [Related]
3. Reproductive history and risk of second primary breast cancer: the WECARE study.
Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
[TBL] [Abstract][Full Text] [Related]
4. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study.
Brooks JD; Boice JD; Stovall M; Reiner AS; Bernstein L; John EM; Lynch CF; Mellemkjær L; Knight JA; Thomas DC; Haile RW; Smith SA; Capanu M; Bernstein JL; Shore RE;
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):917-24. PubMed ID: 22483700
[TBL] [Abstract][Full Text] [Related]
5. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study.
Brooks JD; Boice JD; Shore RE; Reiner AS; Smith SA; Bernstein L; Knight JA; Lynch CF; John EM; Malone KE; Mellemkjaer L; Langballe R; Liang X; Woods M; Tischkowitz M; Concannon P; Stram DO;
Breast; 2020 Dec; 54():62-69. PubMed ID: 32927238
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for contralateral breast cancer in Chennai (Madras), India.
Gajalakshmi CK; Shanta V; Hakama M
Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis.
Akdeniz D; Schmidt MK; Seynaeve CM; McCool D; Giardiello D; van den Broek AJ; Hauptmann M; Steyerberg EW; Hooning MJ
Breast; 2019 Apr; 44():1-14. PubMed ID: 30580169
[TBL] [Abstract][Full Text] [Related]
9. Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.
Knight JA; Fan J; Malone KE; John EM; Lynch CF; Langballe R; Bernstein L; Shore RE; Brooks JD; Reiner AS; Woods M; Liang X; Bernstein JL;
Int J Cancer; 2017 Sep; 141(5):916-924. PubMed ID: 28524234
[TBL] [Abstract][Full Text] [Related]
10. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.
Brooks JD; John EM; Mellemkjaer L; Lynch CF; Knight JA; Malone KE; Reiner AS; Bernstein L; Liang X; Shore RE; Stovall M; ; Bernstein JL
Cancer Med; 2016 Nov; 5(11):3282-3291. PubMed ID: 27700016
[TBL] [Abstract][Full Text] [Related]
11. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint
Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK
Eur J Cancer; 2017 Apr; 75():5-13. PubMed ID: 28214658
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Gao X; Fisher SG; Emami B
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways.
Vichapat V; Gillett C; Fentiman IS; Tutt A; Holmberg L; Lüchtenborg M
Eur J Cancer; 2011 Sep; 47(13):1919-27. PubMed ID: 21658939
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania.
Jordan I; Hebestreit A; Swai B; Krawinkel MB
Breast Cancer Res Treat; 2013 Nov; 142(1):133-41. PubMed ID: 21104009
[TBL] [Abstract][Full Text] [Related]
16. Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.
Sisti JS; Bernstein JL; Lynch CF; Reiner AS; Mellemkjaer L; Brooks JD; Knight JA; Bernstein L; Malone KE; Woods M; Liang X; John EM;
Springerplus; 2015; 4():825. PubMed ID: 26751177
[TBL] [Abstract][Full Text] [Related]
17. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
Tamimi RM; Spiegelman D; Smith-Warner SA; Wang M; Pazaris M; Willett WC; Eliassen AH; Hunter DJ
Am J Epidemiol; 2016 Dec; 184(12):884-893. PubMed ID: 27923781
[TBL] [Abstract][Full Text] [Related]
18. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
[TBL] [Abstract][Full Text] [Related]
19. Contralateral breast cancer: a clinico-pathological study of second primaries in opposite breasts after treatment of breast malignancy.
Shankar A; Roy S; Malik A; Kamal VK; Bhandari R; Kishor K; Mahajan M; Sachdev J; Jeyaraj P; Rath G
Asian Pac J Cancer Prev; 2015; 16(3):1207-11. PubMed ID: 25735357
[TBL] [Abstract][Full Text] [Related]
20. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.
Li CI; Daling JR; Porter PL; Tang MT; Malone KE
J Clin Oncol; 2009 Nov; 27(32):5312-8. PubMed ID: 19738113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
